Last week, the pharmaceutical giant Merck filed a lawsuit against the U.S. Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS). The complaint characterizes the provision detailing the process of Medicare drug price negotiations established by the Inflation Reduction Act (IRA) as “tantamount to extortion.” In addition, the […]

Author